Greta Preatoni is introducing MYNERVA, a groundbreaking neurostimulating medical device designed to address the challenges of diabetic neuropathy, providing a solution that restores the sense of touch and reduces chronic pain. Through strategic electrode placement in a sock and AI algorithms targeting nerves, MYNERVA empowers patients to regain control of their lives, offering a significant advancement in managing the impact of diabetic neuropathy on quality of life.
Greta Preatoni is the CEO & Co-Founder of MYNERVA, a medtech startup that produces a medical device to artificially restore the sense of touch and decrease pain in patients suffering from diabetic neuropathy. Her academic journey took her from Italy, where she completed her Master’s in neuroscience, to Zurich. There, she started her PhD at the Neuroengineering Laboratory of ETH Zurich, where MYNERVA was first born as a research project and soon evolved into a promising product.